However, in a pilot study of treatment with the CTLA-4 Ig fusion protein abatacept, Warnatz et al. reported favorable results in five of eight CVID patients with ILD [46], and a case report of two GLILD patients describes successful treatment with the mTOR inhibitor sirolimus [47]. This evidence concerns the gene MTOR and interstitial lung disease.